Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation

Holtan, S. G., Martens, M. J., Al Malki, M. M., Efebera, Y., Kitko, C. L., Reshef, R., Rezvani, A. R., Shaffer, B. C., Solh, M. M., Yao, J. M., Runaas, L., Elmariah, H., Larkin, K. T., El Jurdi, N. H., Gooptu, M., Loren, A. W., Hall, A. C., Alousi, A., Jamy, O., … Bolanos-Meade, J. (2023). Patient-Reported Outcomes of BMT CTN 1703: A Randomized Phase III Study for Gvhd Prophylaxis - a Quality of Life Evaluation. Blood, 142(Supplement 1), 897–897. https://doi.org/10.1182/blood-2023-187859
Authors:
Shernan G. Holtan
Michael Märtens
Monzr M. Al Malki
Yvonne A. Efebera
Carrie L. Kitko
Ran Reshef
Andrew R. Rezvani
Brian C. Shaffer
Melhem Solh
Janny M. Yao
Lyndsey Runaas
Hany Elmariah
Karilyn Larkin
Najla H El Jurdi
Mahasweta Gooptu
Alison W. Loren
Aric C. Hall
Amin M. Alousi
Omer Jamy
William Clark
Leslie S. Kean
Ami S. Bhatt
Miguel‐Angel Perales
Kristy Applegate
Juan Wu
Eric Liefer
Nancy DiFronzo
Richard J. Jones
Mary M. Horowitz
Deborah Mattila
Mehdi Hamadani
Javier Bolaños‐Meade
Affiliated Authors:
Ran Reshef
Publication Type:
Article
Unique ID:
10.1182/blood-2023-187859
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: